Median Technologies SA (EPA:ALMDT)

France flag France · Delayed Price · Currency is EUR
3.090
-0.070 (-2.22%)
Dec 5, 2025, 5:35 PM CET
3.00%
Market Cap 114.38M
Revenue (ttm) 23.38M
Net Income (ttm) -21.99M
Shares Out 36.20M
EPS (ttm) -1.16
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 85,151
Average Volume 192,301
Open 3.175
Previous Close 3.160
Day's Range 3.060 - 3.175
52-Week Range 1.192 - 5.260
Beta 0.49
RSI 54.36
Earnings Date Apr 28, 2026

About Median Technologies

Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiops, an end-to-end AI-powered technology software as a medical device for early diagnosis of cancers and fibrotic diseases; iSee for image analysis services in clinical trials; and iCRO, which engages in the sale of imaging services for clinical trials in oncology using software. The company was founded in 2002 and is based in Valbonne, ... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2002
Employees 225
Stock Exchange Euronext Paris
Ticker Symbol ALMDT
Full Company Profile

Financial Performance

In 2024, Median Technologies's revenue was 22.96 million, an increase of 0.79% compared to the previous year's 22.78 million. Losses were -25.24 million, 9.83% more than in 2023.

Financial Statements

News

There is no news available yet.